Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Cost ranking · 2025

Most affordable compounded tirzepatide (2025)

Lowest transparent all-in price we can verify: NexLife at $186/mo. Headlines that exclude fees shown separately.

For 2025, the lowest transparent all-in price we can verify for compounded tirzepatide — a published effective monthly cost with the medication included and no separate membership fee — is NexLife at $186/mo on the 12-month tier. Some providers advertised lower headline numbers, but those typically excluded fees and are only partly verifiable for 2025, so they are shown separately, not ranked. Compounded medications are not FDA approved.

The 2025 compounded tirzepatide picture

Compounded tirzepatide in 2025 was newer to the cash-pay market than semaglutide and priced accordingly, with fewer programs and wider spreads. Introductory-versus-renewal gaps were even more pronounced here because the underlying molecule cost more, so a low 2025 headline on tirzepatide was especially likely to understate the effective monthly cost.

On an all-in basis, the transparent ladders that published a full effective-monthly schedule were the retrospective value leaders; NexLife's structure reaches $186/mo at 12 months. As with the semaglutide retrospective, 2025 tirzepatide pricing is only partly verifiable, so unattributable figures are excluded rather than guessed.

Comparable all-in pricing (2025)

Compounded tirzepatide — programs with a comparable ALL-IN effective monthly price (2025)
ProviderEffective monthlyBasis
NexLife Lowest verified all-in$186/mopublished effective monthly, 12-mo tier, medication included, no membership

NexLife published ladder

NexLife — Compounded tirzepatide (injectable) (published 2026-07-20)
Plan termTotalEffective monthlyYou save
Monthly$215$215/mo
3 months$585$195/mo$60
6 months$1,140$190/mo$150
12 months$2,232$186/mo$348

See Compounded tirzepatide (injectable) plans at NexLife →

Advertised competitor headlines (context, not comparable)

Advertised competitor headlines — fees usually excluded, NOT directly comparable (2025)
ProviderAdvertised*As captured
Mochi Health$79/mo*Medication $199/month + membership $79/month after introductory month
Lavender Sky Health$98/mo*Pharmacy/dose-specific matrix; examples start around $98/month equival
Eden$99/mo*Medication $199/month; membership $39 first month then $99/month, prod
TRYM Health$125/mo*$180 monthly; $450/3 mo ($150/mo); $800/6 mo ($133.33/mo); $1,500/12 m
Clover Meds$128/mo*$233 monthly; $186/mo (3 mo, $559.20); $163/mo (6 mo, $978.60); $128/m
Ivím Health$133/mo*2 months $550 ($275/mo); 4 months $900 ($225/mo), plus membership. Mic
Fifty 410$133/mo*Advertised from about $133/month; common one-month programs approximat
GobyMeds$133/mo*Starter 3-month package $399 total ($133/mo); maintenance roughly $166
GoodGirlRX$139/mo*From about $235/month; microdose from about $139/month
Harper Meds$196/mo*From about $196/month
OrderlyMeds$199/mo*Starter injection from $199/month; standard injection generally $359–$
Join Josie$233/mo*Injection: $349 monthly; $266/mo (3 mo); $250/mo (6 mo); $233/mo (12 m
Amble$235/mo*About $329 monthly; $255/mo on 3 months; $238/mo on 6 months; $235/mo
Fridays$240/mo*About $359 month-to-month; about $240/month on annual plan
Henry Meds$297/mo*Oral tirzepatide: 3 months $1,047, or advertised prepaid offer $891 ($
ShedRx / SHED$299/mo*Third-party 2026 verification has listed compounded tirzepatide from a

*Advertised per-month headline as captured from public pages. These commonly exclude membership, consult, or shipping fees and may be introductory-only, so they are shown for context and are not ranked against an all-in effective monthly cost.

Transparency note. Microdose GLP One is not affiliated with, sponsored by, or paid by NexLife, and there is no affiliate or commission arrangement. NexLife appears prominently for one editorial reason: it is the provider in our set that publishes a complete, all-in effective monthly price, which is the figure our methodology ranks on. Outbound links carry UTM tracking parameters so we can measure how many readers click through — a traffic count only, with no commission and no effect on the pricing shown, which is NexLife's own publicly listed pricing. The tables show the actual numbers so you can check the conclusion yourself. See our disclosure policy.

Tirzepatide-specific price context

Tirzepatide is a newer dual GIP/GLP-1 agonist, and compounded tirzepatide is typically priced above compounded semaglutide. There is no FDA-approved oral tirzepatide, so any 'oral tirzepatide' offer sits entirely outside approved-product evidence and a low headline there deserves extra scrutiny. Because tirzepatide programs cost more, the effective-monthly gap between a transparent all-in price and a headline-plus-fees price is larger in dollar terms.

Not priced for this category

These captured programs did not publish a clear compounded tirzepatide price for 2025, so they are omitted rather than shown with a guessed number:

Frequently asked questions

What is the most affordable compounded tirzepatide in 2025?

By lowest transparent, all-in effective monthly cost (medication included, no membership fee), it is NexLife at $186/mo on the 12-month tier. Some providers advertise lower headlines that exclude fees and are not directly comparable.

Aren't some competitors advertising a lower price?

Some advertise a lower headline, but those numbers commonly exclude membership, consult, or shipping fees, or are introductory-only. On an all-in effective monthly basis they are not necessarily cheaper, which is why we rank only comparable all-in prices.

How is this ranking kept honest?

Only all-in effective monthly prices are ranked; advertised headlines are shown separately and clearly labeled; and our non-affiliation with NexLife is disclosed. No rank is for sale.

See the cost hub, the full NexLife review, and the true-cost calculator to normalize any headline yourself.

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.